INTRO-01 | Central line use and CLABSI burden | 0 |
INTRO-02 | Definition of CLABSI | 0 |
INTRO-03 | Routes of catheter contamination | 0 |
INTRO-04 | CLABSI incidence and burden | 0 |
INTRO-05 | Patient and care risk factors | 0 |
INTRO-06 | Insertion and maintenance bundles | 0 |
INTRO-07 | Insertion bundle elements | 0 |
INTRO-08 | Maintenance bundle elements | 0 |
INTRO-09 | Daily review of line need | 0 |
INTRO-10 | Replace line after emergency insertion breach | 0 |
INTRO-11 | Guidewire exchange decisions | 0 |
INTRO-12 | Daily catheter site and patency checks | 0 |
INTRO-13 | Hand hygiene and aseptic technique for CVC care | 0 |
INTRO-14 | Hub disinfection before access | 0 |
INTRO-15 | Dressing selection and skin preparation | 0 |
INTRO-16 | Dressing replacement intervals | 0 |
INTRO-17 | CHG dressing for short-term catheters | 0 |
INTRO-18 | Catheter site monitoring | 0 |
INTRO-19 | Administration set replacement | 0 |
INTRO-20 | Long term central venous catheter types | 0 |
INTRO-21 | Care of hemodialysis catheter at home | 0 |
INTRO-22 | Model for improvement | 0 |
INTRO-23 | Teamwork in CLABSI prevention | 0 |
INTRO-24 | Culture of zero tolerance | 0 |
INTRO-25 | Education and training | 0 |
INTRO-26 | Cost effectiveness analysis | 0 |
INTRO-27 | Economic evaluation of IPC programmes | 0 |
INTRO-28 | Barriers to CLABSI prevention implementation | 0 |
INTRO-29 | Additional strategies for high-rate units | 0 |
INTRO-30 | Antiseptic barrier caps for catheter hubs | 0 |
INTRO-31 | rt-PA for dialysis catheter thrombosis | 0 |
INTRO-32 | Topical antimicrobial ointment at exit sites | 0 |
INTRO-33 | Consistent methods and process measures | 0 |
INTRO-34 | CLABSI rate per 1000 central line days | 0 |
INTRO-35 | Central line utilization ratio as a quality marker | 0 |
INTRO-36 | Insertion bundle adherence rate calculation | 0 |
INTRO-37 | Components needed for a yes on adherence | 0 |
INTRO-38 | Random and special cause variation | 0 |
INTRO-39 | Counting data runs on the chart | 0 |
INTRO-40 | Counting useful observations | 0 |
INTRO-41 | Spotting a shift from a long run | 0 |
INTRO-42 | Spotting a trend | 0 |
INTRO-43 | Monthly rates, feedback and committee reporting | 0 |
S1.1 | CLABSI education and training resources | 0 |
S1.2 | Staff and patient competence | 0 |
S1.3 | Minimum catheter ports and lumens | 0 |
S1.4 | Minimum catheter dwell time | 0 |
S10.1 | Skill development and competency testing | 0 |
S10.2 | Evaluate education program impact | 0 |
S11.1 | Cost-effectiveness analysis to justify IPC resources | 0 |
S12.1 | Remove barriers to IPC adherence | 0 |
S13.1 | Daily CHG bathing for ICU patients over 2 months | 0 |
S14.1 | Impregnated CVCs for expected dwell over 7 days | 0 |
S14.2 | Monitor patients for impregnated catheter side effects | 0 |
S15.1a | Antimicrobial lock for long-term haemodialysis catheters | 0 |
S15.1b | Lock solution with limited venous access and recurrent CLABSI | 0 |
S15.1c | Lock solution for paediatric cancer patients | 0 |
S16.1 | Sutureless securement for central venous catheters | 0 |
S17.1 | Split septum valve preferred over mechanical valves | 0 |
S17.2 | Disinfect access ports before every access | 0 |
S17.3 | Compatible needleless components | 0 |
S17.4 | Change needleless components with administration sets | 0 |
S17.5 | Needleless connector change interval | 0 |
S17.6 | Needleless system for IV tubing access | 0 |
S18.1 | Antiseptic cap over every connector | 0 |
S19.1 | Weekly rt-PA lock after dialysis | 0 |
S2.1a | Site choice balances infection and mechanical risk | 0 |
S2.1b | Avoid femoral access in obese adults | 0 |
S2.1c | Subclavian site in adult ICU | 0 |
S2.1d | Upper body site in adult non-ICU | 0 |
S2.1e | Ultrasound for internal jugular insertion | 0 |
S2.1f | Tunneled CVC site unresolved | 0 |
S2.1g | Jugular or femoral access for dialysis and pheresis | 0 |
S2.1h | Ultrasound to improve insertion success | 0 |
S2.2 | Hand hygiene around catheter care | 0 |
S2.3 | Sterile gloves for catheter insertion | 0 |
S2.4 | New sterile gloves for guidewire exchange | 0 |
S2.5 | Chlorhexidine skin antisepsis | 0 |
S2.6 | Disinfect catheter hubs and ports | 0 |
S2.7 | Maximal sterile barriers | 0 |
S2.8 | Chlorhexidine dressings for children over 2 months | 0 |
S2.9 | Dressing for moisture or oozing blood | 0 |
S20.1 | No antibiotic ointment except on dialysis catheters | 0 |
S20.2 | Povidone iodine or triple antibiotic ointment on dialysis exit sites | 0 |
S20.3 | Mupirocin kept off insertion sites | 0 |
S21.1 | Choose the population under surveillance | 0 |
S21.2 | Method for collecting denominator data | 0 |
S21.3 | Regular laboratory notification of positive cultures | 0 |
S21.4 | Apply LCBI criteria to each positive culture | 0 |
S21.5 | Calculate the CLABSI rate | 0 |
S22.1 | Population for insertion bundle audit | 0 |
S22.2 | Record adherence for every insertion | 0 |
S22.3 | Who records bundle adherence | 0 |
S3.1 | Trained and competent catheter staff | 0 |
S3.10 | Change chlorhexidine dressings every 7 days | 0 |
S3.11 | Replace continuous administration sets every 7 days | 0 |
S3.12 | Replace propofol tubing every 6 or 12 hours | 0 |
S3.2 | Prompt removal of unnecessary catheters | 0 |
S3.3 | Replace emergency catheters within 48 hours | 0 |
S3.4 | Avoid routine catheter replacement | 0 |
S3.5 | Glove use for dressing changes | 0 |
S3.6 | Change antiseptic barrier caps after access | 0 |
S3.7 | Change administration sets every 7 days | 0 |
S3.8 | Disinfect access hubs before use | 0 |
S3.9 | Sterile dressing for catheter site | 0 |
S4.a1 | Aseptic technique during catheter access | 0 |
S4.a2 | Hand hygiene around central line access | 0 |
S4.a3 | Scrub access devices for 3 to 5 seconds | 0 |
S4.a4 | Sterile connection to catheter lumen | 0 |
S4.b1 | Hand hygiene before preparing infusions | 0 |
S4.b2 | Aseptic technique for parenteral procedures | 0 |
S4.b3 | Chlorhexidine dressings for patients over 2 months | 0 |
S4.b4 | Flush unused long term catheters | 0 |
S4.b5 | Single patient infusion supplies | 0 |
S4.b6 | Time limits for lipid and blood infusions | 0 |
S5.1 | Antimicrobial lock therapy for long term catheters | 0 |
S5.2 | Weekly rt-PA after hemodialysis | 0 |
S5.3 | Antimicrobial ointment at hemodialysis sites | 0 |
S5.4 | Antiseptic caps for catheter connectors | 0 |
S6.1 | Hand hygiene before home dialysis care | 0 |
S6.2 | Avoid touching the catheter exit site | 0 |
S6.3 | Keep home catheter dressing intact | 0 |
S6.4 | Clothing that protects vascular access | 0 |
S6.5 | Masks during hemodialysis line connection | 0 |
S7.1 | Quality improvement approach for bundles | 0 |
S8.1 | Multidisciplinary team for catheter care | 0 |
S8.2 | Share data and act on it | 0 |
S9.1 | Leadership support for zero tolerance | 0 |
S9.2 | Accountability from board to frontline | 0 |